Where does Pharma MAR, S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Pharma MAR, S.A. ranks #17,997 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Pharma MAR, S.A. hold?

Pharma MAR, S.A. holds 16 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Pharma MAR, S.A.'s Innovation Score?

Pharma MAR, S.A. has an Innovation Score of 52.1 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Pharma MAR, S.A. focus on?

Pharma MAR, S.A.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 15 patents, ranking #1,291 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Pharma MAR, S.A.'s patent grant rate increasing or decreasing?

Pharma MAR, S.A.'s recent grant velocity is -14% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Pharma MAR, S.A.'s patents?

Pharma MAR, S.A.'s patents average 27.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Pharma MAR, S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Pharma MAR, S.A.

USPTO PatentsView assignee record - 16 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Pharma ranks #17,997 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 9 technology areas.

#17,997
of 49,997 US assignees by volume: Top 11%
by Innovation Score (52.1/100): 27.3
avg claims per patent: -14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17997 · Foreign Corporation #17,997 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,997/49,997
PHOTO-FINISH Peacock Apparel Group
CPC-NARROW A61P · 9 areas
INNOV-PAR 52.1/100
CLAIMS-DENSE 27.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Peacock Apparel Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Pharma’s 52.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (19%) Velocity 16.7 pts (32%) Breadth 10.6 pts (20%) Claim depth 15.0 pts (29%)

Qualcomm Incorporated · highest

85
Gracewood Management · near

52
UncommonX · near

52
Axsome Malta · near

52
Intersil Americas · near

52
Pharma MAR · this assignee

52
3D Lighting… · lowest

7

What this shows Pharma's Innovation Score is 52.1/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Pharma?

Each dot is one of Pharma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pharma’s own 27.3 claims/patent is ABOVE the 9.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Pharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Pharma's grants concentrate

Pharma MAR, S.A. is a focused PatentsView assignee: 9 CPC subclasses with 93.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Pharma sits between Peacock Apparel Group, Inc. and Plastic Omnium NEW Energies France.

Pharma's three-year grant acceleration

Pharma MAR, S.A. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Peacock Apparel G…

16
Perseus Proteomics

16
PGI Drug Discovery

16
Pgytech

16
Pkware

16
Plant Growers Aus…

16
Plant Health Care

16
Plastic Omnium NE…

16
Pharma MAR ◀

16

What this shows Pharma holds 16 patents at rank #17,984, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Pharma

By rank, the assignees closest to #17,984 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Pharma's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Pharma, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Pharma ranks #1,291 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Axsome Malta Ltd. 52 Intersil Americas LLC 52 Gracewood Management, Inc. 52 UncommonX Inc. 52

Pharma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Pharma MAR, S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	18.8%
2016	1	6.3%
2017	2	12.5%
2019	1	6.3%
2020	1	6.3%
2022	3	18.8%
2023	2	12.5%
2025partial year	3	18.8%

Which technologies does Pharma MAR, S.A. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

C07D - Heterocyclic Compounds 12

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 3

C07J - Steroids 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Pharma MAR, S.A.'s patent record in context - here's where to go next.

Pharma MAR, S.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 93.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #17,997 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Pharma MAR, S.A. against Peacock Apparel Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.